Lucca, Italy

Guido Bocci

This inventor holds 1 USPTO granted patent. Top assignee: Societe De Conseils De Recherches Et D'applications Scientifiques Sas. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guido Bocci. Retrieved from https://idiyas.com/inventor/guido-bocci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guido Bocci: Innovator in Pharmaceutical Compositions

Introduction

Guido Bocci is a notable inventor based in Lucca, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of vascular proliferation. His innovative approach has the potential to impact many patients in need of effective therapies.

Latest Patents

Guido Bocci holds 1 patent for his invention titled "Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof." This patent describes a method for treating vascular proliferation by administering a therapeutically effective amount of a type-1 somatostatin agonist to patients requiring such treatment.

Career Highlights

Bocci is associated with the company Societe De Conseils De Recherches Et D'applications Scientifiques Sas, where he applies his expertise in pharmaceutical research and development. His work focuses on creating innovative solutions that address critical health issues.

Collaborations

Throughout his career, Guido has collaborated with esteemed colleagues, including Michael DeWitt Culler and Romano Danesi. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Guido Bocci's contributions to the field of pharmaceuticals exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements in treatment methodologies, benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…